Vale Biolabs Pre-Seed

Swiss biotech startup Vale Biolabs has secured €164,000 (CHF 150,000) in pre-seed funding from Venture Kick to advance its drug discovery platform. Led by a four-person founding team across organoid neurobiology, automation, and data science, the company utilizes standardized human brain organoids and predictive AI to improve preclinical testing for neurological conditions like Alzheimer's and Parkinson's. The capital will be deployed to expand its miniature brain tissue models, advance its automated monitoring platform, generate validation datasets for its AI models, and accelerate collaborations with research and industry partners.